



Diabetes mellitus (DM) is a metabolic disorder characterized 
by chronic hyperglycemia from relative insulin deficiency, 
resistance, or both.[1] The estimated global prevalence of 
DM among adults aged 20–79 years in 2019 was reported 
by the International Diabetes Foundation to be 9.3%, 
affecting 463.0 million adults, and this figure is projected 
to increase to 578.4 million by 2030 and eventually, to 
700.2 million adults, in 2045.[2] A recent systematic review 
of DM prevalence in Nigeria (2018), revealed a nation-wide 
prevalence of 5.7%, though with marked regional variations 
in prevalence.[3] Type 2 DM (T2DM) is the most common 
type of DM and results from a combination of insulin 
resistance and less severe insulin deficiency.[1] T2DM is 
also the most commonly seen diabetes presentation in 
older adults, though in recent times, it has been noted to 
be increasing in incidence among children, adolescents, 
and younger adults due to poor diet, obesity, and sedentary 
lifestyle.
DM as a complex chronic disease, requires multifactorial 
risk-reduction strategies beyond glycemic control.[4] The 
long‑term metabolic derangement in DM leads to the affectation 
of different organs and systems in the body including the 
kidneys, nerves, eyes, and cardiovascular system. Insulin is the 
key hormone required for the storage and controlled release of 
chemical energy in form of glucose from food in the body[1] 
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and hence, is the primary determinant of glycemic control. The 
landmark United Kingdom Prospective Diabetes Study showed 
that patients with tight control of glycaemia had fewer chronic 
complications;[5] therefore, adequate glycemic control should 
be the primary aim of treatment. Short-term glycemic control 
of patients can be determined by self-monitoring of blood 
glucose using glucose meters.[6] However, the glycosylated 
hemoglobin (HbA1c) levels, reflects the average glycemia over 
approximately 3 months and has a strong predictive value for 
DM complications.[5,6]
Calcium is a protean intracellular messenger involved in 
many biological processes.[7] More than 99% of the calcium 
present in the human body is in the bone, the remaining 
being found mostly in the blood and extracellular fluid.[8] The 
biologically active form of calcium is the unbound (ionized) 
form and this ionized calcium needs to be maintained within 
a narrow range, because of the critical role it plays in a wide 
range of cellular functions.[8] Calcium is mainly regulated by 
parathyroid hormone (PTH) and Vitamin D and to a lesser 
extent, by calcitonin.[9]
Insulin secretion is a complex physiologic process which is 
highly calcium-dependent, and occurs following a Vitamin 
D-mediated surge in intracellular calcium. This surge then 
triggers activation of calcium-dependent phospholipid protein 
kinase, which through intermediary pathways, leads to fusion of 
insulin-containing granules to the cell membrane of the pancreatic 
islets beta cells, with subsequent release of insulin-rich granule 
contents.[1] In situations where calcium levels are too low or too 
high, the pancreatic islets and insulin target cells then fail to 
respond appropriately to the physiologic stimulus.[8]
Reduced serum calcium in patients with T2DM is attributed to 
excessive urinary calcium loss due to chronic hyperglycemia. 
PTH secretion is then stimulated in response to increased 
urinary calcium loss, to help maintain serum calcium levels.[10]
The aim of this study was to determine the serum calcium levels 
in participants with T2DM and to determine any relationship 
between serum calcium levels, clinical features of DM patients 
and their HBA1c levels.
MaterIals and Methods
This was a cross-sectional study carried out at the once 
weekly diabetes clinic of the University of Nigeria Teaching 
Hospital (UNTH) Enugu State Nigeria, over a 7 months period, 
from January to July 2017.
Study population
One hundred and fifty sequentially presenting and consenting 
adults were recruited through systematic random sampling 
from the diabetes clinic. One hundred and fifty age‑ and 
gender-matched nondiabetic participants were recruited as a 
comparator group.
Patients with renal disease and other endocrine diseases were 
excluded from the study.
Ethical Clearance was obtained from the Health Research 
and Ethics Committee of UNTH. Details of the study were 
explained to the participants and written informed consent 
obtained for each participant. Data were collected with the 
aid of a structured questionnaire and additional clinical data 
were obtained from the medical records to aid in determining 
participants’ eligibility.
The procedure was clearly explained to all the study participants. 
For all the participants, 3 ml of blood was collected into a 
plain bottle and allowed to clot for 3 min, then centrifuged for 
10 min. The serum was separated and used for the estimation of 
serum calcium using the colorimetric method. Three milliliters 
of blood was collected into an ethylenediaminetetraacetic 
acid bottle for HbA1c estimation for the participants with 
DM. The blood samples were stored at a temperature of 
2°C–8°C and analyzed within 24 h using an automated HbA1c 
machine (In2itTM (I) system). Fasting blood glucose for the 
controls was done to exclude DM, and was estimated with the 
aid of Accu-Check Active® glucometers and test strips which 
uses the hexokinase method for glucose estimation, with results 
comparable to blood glucose concentrations in venous plasma 
as recommended by the International Federation of Clinical 
Chemistry and Laboratory Medicine.
Data collected from this study were analyzed using the  SPSS 
statistical package version 22 (Chicago, IL, USA). Mean and 
standard deviation was used for the continuous variables. 
Chi-square test was used to compare the differences in 
the demographic characteristics of the study population. 
Independent t‑test was used to compare the mean difference 
of serum calcium between the DM participants and healthy 
controls. Characteristics of patients with and without 
hypocalcemia were also compared, using Chi-square for 
categorical variables and Student’s t-test for continuous 
variables. Pearson’s correlation coefficient was used to 
correlate serum calcium level with HbA1c in participants with 
T2DM. In all, critical P < 0.05 was regarded as significant, and 
conclusions were drawn based on this level of significance.
results
The mean ages of both the T2DM participants and controls 
were comparable at 61.54 ± 8.70 years and 61.21 ± 9.08 years, 
respectively (P = 0.91). The gender distribution of both the 
DM participants and control were also similar. The DM group 
had 61 males and 89 females, while the control group had 
65 males and 85 females. Other demographic characteristics 
are shown in Table 1.
As shown in Table 2, the mean serum calcium level in the 
DM participants was significantly lower when compared to 
nondiabetes control group (P = 0.02).
Clinical characteristics of the subjects with diabetes 
mellitus
A total of 94 (64%) patients had DM for >5 years. Treatment 
was done with one or more oral medication in 133 patients, 
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whereas 17 (11.3%) were on both insulin and oral drugs. 
There was no significant difference between the calcium 
levels of males (2.18 ± 0.16) and females (2.19 ± 0.18) with 
diabetes, P = 0.13. Other clinical characteristics of the T2DM 
participants with and without hypocalcemia are illustrated in 
Table 3.
The mean HbA1c for all the participants with T2DM was 
7.09% ± 2.05% and 79 participants (52.7%) had good glycemic 
control using a cut‑off HbA1c level of <7%. The T2DM 
participants who had hypocalcemia had a mean HbA1c of 
7.49 ± 1.98, while those with normal calcium levels had a mean 
HbA1c of 6.90 ± 1.98. Subsequently, there was a significant 
negative correlation between serum calcium and HBA1c in 
participants with T2DM (P = 0.001), as shown in Table 4 and 
illustrated in Figure 1.
dIscussIon
The aim of the present study was to determine the baseline 
serum level of calcium in Nigerian adult participants with 
T2DM compared to controls in addition to correlating serum 
calcium levels with clinical characteristics and their HbA1c.
The age and gender of the DM participants and controls in our 
study were comparable, with no significant difference between 
the two groups.
The prevalence of T2DM has traditionally been known to 
be higher in older adults. However, increasing prevalence is 
now being noticed in young people. Indeed, the American 
diabetes association, in 2012, projected an increase in 
the diagnosis of T2DM in those less 20 years by up to 
49%.[11] Luckily, this worrisome trend is yet to be seen in 
our environment as all the participants with T2DM were 
more than 40 years of age, with the majority of them being 
between 50 and 69 years.
Low-socioeconomic status has also been associated with 
T2DM due to various reasons;[12,13] therefore, it was not 
surprising that participants with T2DM had fewer professionals 
and more artisans when compared to the controls.
Table 2: Comparison of mean serum calcium levels in 
subjects with diabetes mellitus and controls
DM subjects Controls P
Mean serum calcium 2.16±0.17 2.21±0.17 0.02*
*Significant values. DM: Diabetes mellitus
Table 4: Correlation between serum calcium levels and 





Table 1: Sociodemographic characteristics of the study 
subjects







61.54±8.70 61.21±9.08 0.01** 0.91
40-49 10 (6.7) 13 (8.7) 0.55 0.97
50-59 53 (35.3) 53 (35.3)
60-69 62 (41.3) 58 (38.7)
>70 25 (16.6) 26 (17.3)
Gender
Male 61 (40.7) 65 (43.3) 0.22 0.64
Female 89 (59.3) 85 (56.7)
Marital status
Married 132 (88.0) 139 (92.7) 6.14 0.11
Divorced 0 (0.0) 2 (1.3)
Widowed 16 (10.7) 9 (6.0)
Never married 2 (1.3) 0 (0.0)
Occupation
Trader 52 (34.7) 41 (27.3) 7.22 0.21
Farmer 28 (18.7) 32 (21.3)
Professional 16 (10.7) 31 (20.7)
Artisans 35 (23.3) 28 (18.7)
Housewife 6 (4.0) 5 (3.3)
Retired 13 (8.7) 13 (8.7)
**t-test. DM: Diabetes mellitus
Table 3: Comparison of clinical characteristics of type‑2 







<65 33 65 0.130 0.718
≥65 16 36
Gender
Male 18 43 0.466 0.495
Female 31 58
History of smoking
Yes 1 8 2.023 0.155
No 48 93
History of alcohol 
use




Yes 37 83 0.917 0.338
No 12 18
Duration of illness 
(years)




HbA1c ≥7 26 45 0.958 0.328
HbA1c <7 23 56
HbA1c: Glycosylated hemoglobin
Nigerian Journal of Medicine ¦ Volume 29 ¦ Issue 2 ¦ April-June 2020 231
Nwankwor, et al.: Hypocalcemia in T2DM correlates negatively with HbA1c
There were more patients with long duration of diabetes 
(>5 years). This may have contributed to the relatively poor 
glycemic control in the DM subjects, as a longer duration 
of diabetes may result in declining beta-cell function and 
attendant poor glycemic control.
The results from this study showed that serum calcium levels 
were significantly reduced in participants with T2DM compared 
to normal subjects (2.16 ± 0.17 vs. 2.21 ± 0.17, respectively, 
P = 0.02). This decrease in serum calcium levels may be 
attributed to a number of factors. First, there is a heightened 
urinary loss of calcium as a result of hyperglycemia, which has 
been described by Sultan et al.[14] and this urinary calcium loss 
has been found to be proportional to the degree of glycosuria. 
In addition, volume depletion, which is common among T2DM 
subjects, may induce varying degrees of renal impairment, 
resulting in poor excretion of phosphorus and ultimately, 
high phosphate levels. The high levels of phosphorous then 
accumulate and avidly binds ionized calcium in the blood, 
resulting in hypocalcemia.[15] Furthermore, overtime, there is a 
gradual reduction in the secretion of PTH, (an effect mediated 
by hypomagnesemia – commonly seen in patients with 
diabetes), which may subsequently contribute to the disruption 
in calcium homeostasis, with resultant hypocalcemia.[15] 
This finding resonates with reports by several researchers 
elsewhere, who also found a significant reduction in the mean 
serum calcium levels of their DM participants compared to 
non-DM subjects/controls[16-18] but differs from that reported 
by Yousif and Ahmed[19] who found no mean difference in the 
level of serum calcium between individuals with diabetes and 
normoglycemic participant. They attributed their finding to 
the relative availability of dietary calcium sources and partial 
control of hyperglycemia in their participants with DM, as 
studies have suggested that calcium optimization lessens the 
symptoms of DM and may even reduce the risk of developing 
T2DM in adults.[15,20] Arun et al.[21] also did not find any 
difference in serum calcium levels between T2DM participants 
with hyperglycemia and those with normoglycemia. However, 
it must be stressed that all their participants had T2DM already 
and were then classified using HbA1c cutoff level of 6.5%. 
Another study by Abubaker and Mohammed[22] in Sudan did 
not show any significant difference between mean serum 
calcium level in participants with DM and control.
From our results, only a fraction above half (52.7%) of the 
T2DM participants had good long-term glycemic control, 
as evidenced by an HbA1c <7%.[23] The T2DM participants 
who had hypocalcemia, had a mean HbA1c of 7.49 ± 1.98 
while those with normal calcium levels had a mean HbA1c 
of 6.90 ± 1.98. These figures eventually revealed a negative 
correlation between serum calcium and HbA1c in participants 
with T2DM (r = −0.273, P ≤ 0.01), suggesting that low 
calcium levels had a deleterious effect on long‑term glycemic 
control. This is not surprising, as cellular calcium signaling, 
strongly regulated by the Vitamin D precursor 1, 25(OH) 2 
D3, has been shown to drive cellular responses and secretion 
in several cell types, including pancreatic secretory cells.[15] 
In addition, sustained calcium signaling is linked with the 
regulation of apoptosis in T2DM and other diseases.[24,25] 
Although various studies report conflicting results in the 
relationship between serum calcium levels and blood glucose 
levels, a relatively large prospective study suggests that 
a daily calcium intake of >1200 mg in combination with 
appropriate amounts of Vitamin D, was associated with a 
33% risk reduction of T2DM, compared with a daily intake 
of <600 mg of calcium.[20] This result is in agreement with 
some earlier reports elsewhere.[16,17,26] In contrast, Yamaguchi 
et al.[27] showed a positive correlation between serum calcium 
and fasting plasma glucose in men (P ≤ 0.5) but not in women. 
It is not clear why their finding was only positive for men. 
HbA1c is known to reflect the average glycemia over a 
3-month period, and fasting plasma glucose only gives the 
current glycemic level at the time of measurement. The fact 
that Yamaguchi et al.[27] used fasting plasma glucose in their 
study may also account for the difference found in their result 
because fasting plasma glucose does not represent effectively, 
long-term control of glycemia.
In the study, the presence of hypocalcemia was not significantly 
related to older age, longer duration of diabetes, or the presence 
of hypertension in the participants with diabetes. This suggests 
that the effect of hypocalcemia on HbA1c levels found in this 
study is largely due to the hypocalcemia per se and unrelated 
to these other factors.
conclusIon
This study found that in participants with T2DM, serum 
calcium levels were lower compared to participants without 
diabetes. There was also a significant negative correlation 
between serum calcium and HbA1c. Screening for serum 
calcium levels may need to be done more frequently, especially 
in those with persistent or recalcitrant hyperglycemia, with a 
view to correcting the low calcium level, if present, as this may 
ultimately translate to better glycemic control.
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Figure 1: Scatter diagram showing a negative correlation between 
serum calcium and glycosylated hemoglobin in Type 2 diabetes mellitus 
subjects (P = 0.001)
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The cross‑sectional nature of the study limits our significant 
findings to mere associations as causality cannot be claimed 
from our results. In addition, point of care glucometers and 
HbA1c testing machines were used to assess fasting blood 
sugar in the controls and long-term glycemic control in 
participants with diabetes, respectively, using finger‑prick 
blood samples. However, results obtained from them have been 
shown to have a fairly good correlation to results obtained in 
the laboratories, using venous plasma.[28,29]
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